Literature DB >> 9547162

Developmental changes in distribution patterns of phencyclidine-induced c-Fos in rat forebrain.

D Sato1, A Umino, K Kaneda, M Takigawa, T Nishikawa.   

Abstract

In the forebrain of 56-day-old rats, histochemical studies revealed that the subcutaneous injection of a psychotomimetic phencyclidine (PCP; 1 and 10 mg/kg) induced a dose-related and dense nuclear c-Fos-like immunoreactivity in the pyriform cortex, layers IV-VI of the neocortex and septum, but a sparse c-Fos immunostaining in the olfactory tubercle and mid-lateral striatum. Infant rats at postnatal day 8 expressed much fewer and more confined c-Fos-positive cells in the neocortex than young adult rats following PCP injection. However, a similar expression pattern of PCP-induced c-Fos was observed in the pyriform cortex, mid-lateral striatum, olfactory tubercle and septum between the infant and adult periods. These developmental changes in the regional distribution of a neuronal activity marker, c-Fos, suggest that neuronal populations involved in PCP-induced abnormal behavior are influenced by postnatal development, at least, in the neocortex.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9547162     DOI: 10.1016/s0304-3940(97)00879-3

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

1.  Testing the validity of c-fos expression profiling to aid the therapeutic classification of psychoactive drugs.

Authors:  B E H Sumner; L A Cruise; D A Slattery; D R Hill; M Shahid; B Henry
Journal:  Psychopharmacology (Berl)       Date:  2003-09-10       Impact factor: 4.530

2.  Neural basis of the potentiated inhibition of repeated haloperidol and clozapine treatment on the phencyclidine-induced hyperlocomotion.

Authors:  Changjiu Zhao; Tao Sun; Ming Li
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-03-26       Impact factor: 5.067

3.  Chronic cocaine administration switches corticotropin-releasing factor2 receptor-mediated depression to facilitation of glutamatergic transmission in the lateral septum.

Authors:  Jie Liu; Baojian Yu; Luis Orozco-Cabal; Dimitri E Grigoriadis; Jean Rivier; Wylie W Vale; Patricia Shinnick-Gallagher; Joel P Gallagher
Journal:  J Neurosci       Date:  2005-01-19       Impact factor: 6.167

4.  Further evidence for a male-selective genetic association of synapse-associated protein 97 (SAP97) gene with schizophrenia.

Authors:  Akihito Uezato; Junko Kimura-Sato; Naoki Yamamoto; Yoshimi Iijima; Hiroshi Kunugi; Toru Nishikawa
Journal:  Behav Brain Funct       Date:  2012-01-06       Impact factor: 3.759

5.  Association studies of WD repeat domain 3 and chitobiosyldiphosphodolichol beta-mannosyltransferase genes with schizophrenia in a Japanese population.

Authors:  Momoko Kobayashi; Daisuke Jitoku; Yoshimi Iwayama; Naoki Yamamoto; Tomoko Toyota; Katsuaki Suzuki; Mitsuru Kikuchi; Tasuku Hashimoto; Nobuhisa Kanahara; Akeo Kurumaji; Takeo Yoshikawa; Toru Nishikawa
Journal:  PLoS One       Date:  2018-01-08       Impact factor: 3.240

6.  Identification of developmentally regulated PCP-responsive non-coding RNA, prt6, in the rat thalamus.

Authors:  Hironao Takebayashi; Naoki Yamamoto; Asami Umino; Toru Nishikawa
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

7.  Reduced cortical expression of a newly identified splicing variant of the DLG1 gene in patients with early-onset schizophrenia.

Authors:  A Uezato; N Yamamoto; Y Iwayama; S Hiraoka; E Hiraaki; A Umino; E Haramo; M Umino; T Yoshikawa; T Nishikawa
Journal:  Transl Psychiatry       Date:  2015-10-06       Impact factor: 6.222

8.  Interneuron Heterotopia in the Lis1 Mutant Mouse Cortex Underlies a Structural and Functional Schizophrenia-Like Phenotype.

Authors:  Raquel Garcia-Lopez; Ana Pombero; Alicia Estirado; Emilio Geijo-Barrientos; Salvador Martinez
Journal:  Front Cell Dev Biol       Date:  2021-07-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.